We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pronova Targets Teva Over Lovaza ANDA

Law360 (April 24, 2009, 12:00 AM EDT) -- Norwegian pharmaceutical company Pronova BioPharma Norge AS has hit Teva Pharmaceuticals USA Inc. with a patent infringement suit over triglyceride-lowering drug Lovaza.

Pronova filed the suit Thursday in the U.S. District Court for the District of Delaware over two patents used in the formulation of Lovaza, which is used to treats high levels of triglycerides, a type of fat found in the bloodstream.

Much like cholesterol, high levels of triglycerides can clog or harden arteries, putting patients at an increased risk of stroke, heart attack, heart...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.